Chapter Activities 

ISPOR Warsaw 2019: 27-28 March; Warsaw, Poland – SAVE THE DATE!

Theme: Navigating Joint HTA, Procurement and Fair Pricing-Evidence-Based Insights and Practical Recommendations

Why Attend?

Registration Fees

Venue and Hotel Information

16th International Conference of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter); 29-30 November 2018; Warsaw, Poland

HTA Development - Challenges, Practical Solutions, and Expected Benefits

The annual conference focused on discussing drug policy in Poland and the future of HTA in the light of new regulations. Other presented topics included: current trends in HEOR, e-health, and reimbursement policy, which were delivered by regional and international panel of experts in healthcare. The conference was opened by Prof Lukasz Szumowski, Minister of Health in the Polish Ministry of Health.

Conference Schedule and Registration 

Program (in Polish)

XV International Conference of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter); 30 November - 1 December 2017; Warsaw, Poland

Drug Pricing in Europe - Fair, Uniform or Both?

The Polish Pharmacoeconomics Society (ISPOR Poland Chapter) held the XV Annual International Conference on 30 November -1 December 2017 in the Hotel Airport Okecie, Warsaw, Poland.

ISPOR Poland Chapter organized the 15th International Conference on 30 November-1 December 2017 in Warsaw, Poland. Dr Maciej Niewada, President of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter), Dr Joanna Lis, Past President; Prof Marcin Czech, Under Secretary of State at the Polish Ministry of Health ), delivered a warm welcome to the attendees of the conference.

The main topic of the conference was, "Drug Pricing in Europe – Fair, Uniform or Both?," was presented by Dr Zoltan Kalo (Hungary) on Thursday, November 30.

A panel discussion on rational medicinal policy in Central and Eastern Europe countries followed the topic and has been moderated by Dr Maciej Niewada. Many experts from European countries participated as speakers at the event, including Dr Jiri Samek (Czech Republic), Prof John Yfantopoulos (Greece), and Prof Tomas Tesar (Slovakia).  

Afternoon session was devoted to the situation of HTA in Poland with presentations of the Polish Agency for Health Technology Assessment representatives.

The second day of the conference, Friday, 1 December, was dedicated to a session on medical devices, followed by session of RWE, Polish EQ-5D-5L valuation study, and HTA in oncology and in hospital setting.

Afternoon session involved student presentations of original studies. 

XIV International Conference of the Polish Pharmacoeconomics Society

(ISPOR Poland Chapter), December 1-2, 2016, Warsaw, Poland

Effective Investment in a Coordinated Health Care

The conference focused on the topic of investing in coordinated care and featured presentations by regional and international experts. The Polish Deputy Minister of Health, Dr. Krzysztof Łanda spoke about the new possibilities for reimbursement of medical devices, amendments in reimbursement act and changes planned in health policies in Poland. ISPOR President, Prof. Lou Garrison, delivered a presentation on “The Second U.S. Panel Report on CEA: Key Findings and Implications for HTA,” and Prof. Ben van Hout presented on good economic practice, sensitivity analysis, and medical devices. The ISPOR CEE Network Chair, Vlad Zah and President of ISPOR Greece Chapter, Prof. John Yfantopoulos participated in a session discussing the potential support of e-health system for reimbursement decision-making. The conference was attended by more than 180 participants and was preceded by series of workshops on health technology assessment, risk-sharing schemes, new HTA guidelines and other hot topics related to HTA in the region. 

The Second U.S. Panel Report on CEA: Key Findings and Implications for HTA Presentation

Patients Registries: The Role of Health System, New Trends and Hopes for Polish Patients,

March 19, 2015, Hotel Radisson Blu Sobieski, Warsaw, Poland

Scientific conference organized under the auspices of the Polish Pharmacoeconomic Society (ISPOR Poland Chapter) and the Journal of Health Policy & Outcomes Research (JHPOR)

Patients registries are collected data, based on a standardized description of the patient and identification of methods used for the procedure, in order to determine the specific effects in the study population. Measured effects can affect different areas: health outcomes, therapeutics or medicine policy, and even the sociology of patients’ behavior.  May patients records improve the functioning of health care? Can we get more benefits from patient registries in Poland? How do other countries use this knowledge? These and other questions will be addressed during the conference by international experts and representatives of the Polish health institutions. The conference will end with the postulate of the "seven milestones", presenting recommendations for the role of patient registries functioning in Poland. For questions, please contact: 

Therapeutic and Diagnostic Device Outcomes Research - Translated into Polish!

The translation has been completed by regional experts and members of ISPOR Poland Chapter


 “Therapeutic and Diagnostic Device Outcomes Research is the first such comprehensive publication available in Polish language, which as a whole deals with the subject of clinical effectiveness assessment and economic efficiency of products used in medical diagnosis and treatment. It provides necessary information for the Polish medical decision makers, payers, health care experts, analysts, clinicians and patients. It is a very important element of Pharmacoeconomic education. We have dealt so far mainly with drugs and now we have a ‘bible’ for medical devices. I am sure that this translation will be welcomed by Polish readers with a high interest and attention.” - Joanna Lis, MSc, PhD, President, ISPOR Poland Chapter.

Those interested in obtaining the Polish translation of the book, please contact: or

For more information on all ISPOR books, visit:



Contact Information

ISPOR Poland Regional Chapter Office

The Polish Pharmacoeconomics Society
ul. Śliska 3 lok. 55
00-127 Warsaw, Poland 

Chapter Leadership


PresidentMaciej Niewada, MD
Past-PresidentJoanna Lis, MSc, PhD
SecretaryMarcin Czech, MD
DirectorWitold Owczarek, MD

More Details


Panel discussion during the 15th International Conference in Warsaw,Poland on 30 November-1 December 2017


Maciej Niewada (Chapter President), Joanna Lis (Chapter Past-President), and Tomasz Hermanowski (Congress Program Committee Co-Chair) at ISPOR European Congress, Vienna 2016


Members of ISPOR Poland Chapter at ISPOR 16th European Congress, Dublin

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now